Once-weekly insulin vs once-weekly tirzepatide demonstrated superior safety profiles but inferior weight loss and glycemic control outcomes.
Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...
Nearly 86 per cent of those with type 2 diabetes have been treated with a new procedure that no longer requires insulin, a ...